← Oncology Approval Tracker

FDA DECISION ·

Imfinzi

durvalumab · AstraZeneca

FDA approvalNew or expanded indicationNon-small cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with resectable non-small cell lung cancer at least 4 cm or node positive and no known EGFR mutation or ALK rearrangement; durvalumab with platinum chemotherapy before surgery and alone afterward.

LAMPGEN ANALYSIS

Why it matters

The AEGEAN-based approval added another perioperative option for the defined population without known EGFR or ALK drivers.

What research teams should watch

Map the treatment and surgery sequence in the source record, including delays, cancellations and whether postoperative treatment began.

PRIMARY RECORDS

Sources